See all

Carey-Ann D. Burnham, PhD, D(ABMM), FIDSA, F(AAM)

Professor of Pathology & Immunology, Molecular Microbiology, Pediatrics, and Medicine

Phone314-362-1547

Fax314-362-1461

Emailcburnham@wustl.edu

Additional Titles

  • Medical Director of Microbiology, Barnes Jewish Hospital
  • Co-Director, Faculty Development Steering Committee
  • Program Director, Medical and Public Health Microbiology Fellowship

Related Links

Education

  • B.Sc., Medical Laboratory Science (With Distinction): University of Alberta, Edmonton, Alberta, Canada (2002)
  • Ph.D., Medical Sciences (Department of Laboratory Medicine and Pathology): University of Alberta, Edmonton, Alberta, Canada (2007)
  • Fellowship in Clinical Microbiology: Washington University School of Medicine, St. Louis, Missouri (2009)

Board Certifications

  • Diplomate, Americian Board of Medical Microbiology, 2009

Recognition

  • The American Society for Microbiology/Siemens Healthcare Diagnostics Young Investigator Award
  • Washington University Laboratory and Genomic Medicine Teacher of the Year
  • The Academy of Clinical Laboratory Physicians and Scientists (ACLPS) Ellis S. Benson Award
  • American Association for Clinical Chemistry (AACC) Outstanding Speaker Award
  • American Society for Clinical Pathology (ASCP) “40 Under 40” Honoree Fellow
  • Infectious Diseases Society of America (FIDSA)
  • WUSM 2018 Distinguished Educator Award (Graduate Medical Education/ Residents or Clinical Fellows) Fellow
  • American Academy of Microbiology (AAM)

Clinical Interests

  • Antimicrobial Resistance
  • Microbiology
  • Bacteriology
  • MALDI-TOF MS
  • Automation

Research Interests

My research efforts are focused on the transmission and epidemiology of multi-drug resistant bacteria, with a focus on the diagnosis and epidemiology of Clostridium difficile and Staphylococcus aureus infections.

Publications

Pub Med Search

Selected Publications:

  • Burnham, C.A., J. Leeds, P. Nordmann, J. O’Grady, and J. Patel. 2017. Viewpoint: Diagnosing Antimicrobial Resistance. Nature Reviews Microbiology. 15: 697-703. PMID: 29021600.
  • McMullen, A., N. Anderson, M.A. Wallace, A. Shupe, and C.A. Burnham. 2017. When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multi-drug Resistant, Opportunistic Pathogen. Antimicrobial Agents Chemotherapy. 61: pii: e01111-17. doi: 10.1128/AAC.01111-17. PMID: 28848008.
  • Pesesky, M., T. Hussain, M. Wallace, S. Patel, S. Andleeb, C.A. Burnham, and G. Dantas. 2016. Evaluation of Machine Learning and Rules-Based Approaches for Predicting Antimicrobial Resistance Profiles in Gram-negative Bacilli from Whole Genome Sequence Data. Front Microbiol. 7:1887. PMID: 27965630.
  • Burnham, C.A., P.G. Hogan, M.A. Wallace, E. Deych, W. Shannon, D.K. Warren, and S.A. Fritz. 2016. Topical Decolonization Does Not Eradicate the Skin Microbiota of Community-Dwelling or Hospitalized Adults. Antimicrobial Agents Chemotherapy. 60: 7303-7312. PMID: 27671074.
  • Warren, D.K., M. Prager, S. Munigala, M.A. Wallace, C.R. Kennedy, K.M. Bommartio, J.E. Mazuski, C.A. Burnham. 2016. Prevalence of qacA/B Genes and Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates in the Setting of Chlorhexidine Bathing Without Mupirocin. Infect Control Hosp Epidemol. 37: 590-597. PMID: 26828094.
  • Wu, M.T., C.A. Burnham, L.F. Westblade, J. Dien Bard, S.D. Lawton, M.A. Wallace, T. Stanley, E. Burd, J. Hindler, and R.M. Humphries. 2016. Evaluation of oxacillin and cefoxitin disk and MIC breakpoints for the prediction of methicillin resistance in human and veterinary isolates of Staphylococcus intermedius group. J Clin Microbiol. 54: 535-542. PMID: 26607988.
  • Gonzales, P.R., M.W. Pesesky, R. Bouley, A. Blaard, B.A. Biddy, M.A. Suckow, W.R. Wolter, V.A. Schroder, C.A. Burnham, S. Mobashery, M. Chang and G. Dantas. 2015. Synergistic, collaterally sensitive beta-lactam combinations suppress resistance in MRSA. Nature Chem Biol. 11: 855-861. PMID: 26368589.
  • Wilen, C.D., A.R. McMullen, and C.A. Burnham. 2015. Comparison of sample preparation, instrumentation platforms, and contemporary commercial databases for MALDI-TOF MS identification of clinically relevant mycobacteria. J Clin Microbiol. 53: 2308-2315. PMID: 25972426.
  • Dubberke, E.D., K. Reske, S. Selier, T. Hink, J. Kwon, and C.A. Burnham. 2015. Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients. Antimicrob Agents Chemotherapy. 59: 4533-4543. PMID: 25987626.
  • McElvania TeKippe, E., B.S. Thomas, G.A. Ewald, S.J. Lawrence, and C.A. Burnham. 2014. Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum…. a cautionary tale. Eur J Clin Microbiol Infect Dis. 33:2199-2205. PMID: 24973133.


Office Location: BJC-IH Building, Room 5802

Assistant
Tammy Robison
Phone: 314-362-2998
tammyrobison@wustl.edu